Immune microenvironments differ in immune characteristics and outcome of glioblastoma multiforme
Abstract Understanding the interactions between tumors and the host immune system holds great promise to uncover biomarkers for targeted therapies, predict the prognosis of patients and guide clinical treatment. However, the immune signatures of glioblastoma multiforme (GBM) remain largely unstudied...
| Published in: | Cancer Medicine |
|---|---|
| Main Authors: | Botao Zhang, Rongfang Shen, Shujun Cheng, Lin Feng |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-06-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.2192 |
Similar Items
Immune-related lncRNAs signature and radiomics signature predict the prognosis and immune microenvironment of glioblastoma multiforme
by: Jixin Luan, et al.
Published: (2024-01-01)
by: Jixin Luan, et al.
Published: (2024-01-01)
Immunological Insights into Photodynamic Therapy of Glioblastoma Multiforme
by: Paweł Woźnicki, et al.
Published: (2025-07-01)
by: Paweł Woźnicki, et al.
Published: (2025-07-01)
Immune intrinsic escape signature stratifies prognosis, characterizes the tumor immune microenvironment, and identifies tumorigenic PPP1R8 in glioblastoma multiforme patients
by: Ran Du, et al.
Published: (2025-08-01)
by: Ran Du, et al.
Published: (2025-08-01)
LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression
by: Chai E, et al.
Published: (2019-08-01)
by: Chai E, et al.
Published: (2019-08-01)
Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme
by: Long Mu, et al.
Published: (2022-12-01)
by: Long Mu, et al.
Published: (2022-12-01)
Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme
by: Xudong Zhang, et al.
Published: (2022-04-01)
by: Xudong Zhang, et al.
Published: (2022-04-01)
Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme
by: Yintao Ye, et al.
Published: (2023-01-01)
by: Yintao Ye, et al.
Published: (2023-01-01)
Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme
by: Dongjie Shi, et al.
Published: (2022-08-01)
by: Dongjie Shi, et al.
Published: (2022-08-01)
Editorial: Improving responses to immunotherapy in glioblastoma multiforme
by: Stephanie E. B. McArdle, et al.
Published: (2024-04-01)
by: Stephanie E. B. McArdle, et al.
Published: (2024-04-01)
A Case With Multicentric Glioblastoma Multiforme
by: Elif Tolgay, et al.
Published: (2008-08-01)
by: Elif Tolgay, et al.
Published: (2008-08-01)
Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
by: Liu Zhiye, et al.
Published: (2023-06-01)
by: Liu Zhiye, et al.
Published: (2023-06-01)
Exploring the multidimensional heterogeneities of glioblastoma multiforme based on sample-specific edge perturbation in gene interaction network
by: Jianglin Zheng, et al.
Published: (2022-08-01)
by: Jianglin Zheng, et al.
Published: (2022-08-01)
Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme
by: Xiaomin Cai, et al.
Published: (2022-10-01)
by: Xiaomin Cai, et al.
Published: (2022-10-01)
Practical immunomodulatory landscape of glioblastoma multiforme (GBM) therapy
by: Seyedeh Elham Norollahi, et al.
Published: (2024-10-01)
by: Seyedeh Elham Norollahi, et al.
Published: (2024-10-01)
Metástases intrarraquidianas de glioblastoma multiforme supratentorial da infância: relato de caso Spinal cord metastatic glioblastoma multiforme of childhood: case report
by: Patricia Imperatriz Porto Rondinelli, et al.
Published: (2002-09-01)
by: Patricia Imperatriz Porto Rondinelli, et al.
Published: (2002-09-01)
Copper-coordination driven brain-targeting nanoassembly for efficient glioblastoma multiforme immunotherapy by cuproptosis-mediated tumor immune microenvironment reprogramming
by: Yang Chen, et al.
Published: (2024-12-01)
by: Yang Chen, et al.
Published: (2024-12-01)
A Rare Cause of Personality Change in Emergency Department: Glioblastoma Multiforme
by: Emin Uysal, et al.
Published: (2017-04-01)
by: Emin Uysal, et al.
Published: (2017-04-01)
Glioblastoma multiforme - disease overview considering sports and neurorehabilitation
by: Monika Niedźwiedzka, et al.
Published: (2024-10-01)
by: Monika Niedźwiedzka, et al.
Published: (2024-10-01)
Advances in immunotherapy for glioblastoma multiforme
by: Ahmad Bakur Mahmoud, et al.
Published: (2022-10-01)
by: Ahmad Bakur Mahmoud, et al.
Published: (2022-10-01)
A Child with Glioblastoma Multiforme — Case Report
by: Anna Rozensztrauch, et al.
Published: (2020-06-01)
by: Anna Rozensztrauch, et al.
Published: (2020-06-01)
Prognosis and Survival Study in Patients with Glioblastoma Multiform and Its Relationship with EGFR Expression
by: Zeinab Amirpour, et al.
Published: (2020-07-01)
by: Zeinab Amirpour, et al.
Published: (2020-07-01)
Integrative Analyses and Verification of the Expression and Prognostic Significance for RCN1 in Glioblastoma Multiforme
by: Weicheng Lu, et al.
Published: (2021-10-01)
by: Weicheng Lu, et al.
Published: (2021-10-01)
High expression of nucleotide-binding oligomerization domain protein 1 correlates with poor prognosis and immune cell infiltration in Glioblastoma Multiforme patients
by: Hongyang Zhao, et al.
Published: (2025-01-01)
by: Hongyang Zhao, et al.
Published: (2025-01-01)
Pediatric glioblastoma multiforme: A single-institution experience
by: Mansour Ansari, et al.
Published: (2012-01-01)
by: Mansour Ansari, et al.
Published: (2012-01-01)
Supratentorial glioblastoma multiforme with spinal metastases
by: Abhidha Shah, et al.
Published: (2010-01-01)
by: Abhidha Shah, et al.
Published: (2010-01-01)
Unlocking the secret of glioblastoma multiforme: the role of lactylation in tumor progression, drug resistance and immune microenvironment
by: Yifei Xiao, et al.
Published: (2025-08-01)
by: Yifei Xiao, et al.
Published: (2025-08-01)
Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide
by: Alexandre Ciuffi Faustino, et al.
Published: (2020-09-01)
by: Alexandre Ciuffi Faustino, et al.
Published: (2020-09-01)
The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions
by: Karam Khaddour, et al.
Published: (2020-11-01)
by: Karam Khaddour, et al.
Published: (2020-11-01)
Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression
by: Salvatore Panza, et al.
Published: (2020-06-01)
by: Salvatore Panza, et al.
Published: (2020-06-01)
Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme
by: Longfei Deng, et al.
Published: (2023-12-01)
by: Longfei Deng, et al.
Published: (2023-12-01)
Glioblastoma multiforme: A rare case of GBM
by: Albert Paul Varghese, et al.
Published: (2024-10-01)
by: Albert Paul Varghese, et al.
Published: (2024-10-01)
Glioblastoma multiforme: Case report of an unusual presentation
by: Niveditha Samala, et al.
Published: (2023-01-01)
by: Niveditha Samala, et al.
Published: (2023-01-01)
Using Light for Therapy of Glioblastoma Multiforme (GBM)
by: Alex Vasilev, et al.
Published: (2020-01-01)
by: Alex Vasilev, et al.
Published: (2020-01-01)
TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas
by: Feng Tang, et al.
Published: (2023-08-01)
by: Feng Tang, et al.
Published: (2023-08-01)
Correlação clínico-topográfica em glioblastomas multiformes nas síndromes motoras: significados fisiopatológicos Clinical topographic findings in glioblastoma multiforme and the relation with motor impairment
by: Rita de Cássia G. Lucena, et al.
Published: (2006-06-01)
by: Rita de Cássia G. Lucena, et al.
Published: (2006-06-01)
Case report of a unique phenomenon: leptomeningeal spread in glioblastoma multiforme
by: Kanza Farhan, et al.
Published: (2025-03-01)
by: Kanza Farhan, et al.
Published: (2025-03-01)
Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment
by: Smita Kumari, et al.
Published: (2023-07-01)
by: Smita Kumari, et al.
Published: (2023-07-01)
Development of an Immune Infiltration-Related Prognostic Scoring System Based on the Genomic Landscape Analysis of Glioblastoma Multiforme
by: Guihua Tang, et al.
Published: (2020-02-01)
by: Guihua Tang, et al.
Published: (2020-02-01)
A Rare Case of Drop Metastasis along Lumbar Column of Glioblastoma Multiforme
by: Rafaela Jucá Lindner, et al.
Published: (2024-12-01)
by: Rafaela Jucá Lindner, et al.
Published: (2024-12-01)
Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme
by: Tanvir Ahmed
Published: (2023-03-01)
by: Tanvir Ahmed
Published: (2023-03-01)
Similar Items
-
Immune-related lncRNAs signature and radiomics signature predict the prognosis and immune microenvironment of glioblastoma multiforme
by: Jixin Luan, et al.
Published: (2024-01-01) -
Immunological Insights into Photodynamic Therapy of Glioblastoma Multiforme
by: Paweł Woźnicki, et al.
Published: (2025-07-01) -
Immune intrinsic escape signature stratifies prognosis, characterizes the tumor immune microenvironment, and identifies tumorigenic PPP1R8 in glioblastoma multiforme patients
by: Ran Du, et al.
Published: (2025-08-01) -
LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression
by: Chai E, et al.
Published: (2019-08-01) -
Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme
by: Long Mu, et al.
Published: (2022-12-01)
